Corporate Social Responsibility | Business Wire | PR NewsWire | Marketwire | Realwire | ACN/JCN newswire | 247pressrelease | PRWeb

Symphogen Opens US Operations in Princeton, New Jersey

COPENHAGEN & PRINCETON, N.J. - 
      Symphogen A/S today announced the opening of its United States 
      headquarters in Princeton, New Jersey.
Posted : Tue, 03 Nov 2009 08:01:00 GMT
Author : Symphogen
Category : Press Release
News Alerts by Email ( click here )
Press Release News | Home
COPENHAGEN & PRINCETON, N.J. - (Business Wire) Symphogen A/S today announced the opening of its United States headquarters in Princeton, New Jersey. Adriann Sax, Symphogen’s recently appointed Chief Business Officer, will head the Company’s US business which will operate as Symphogen, Inc., a wholly-owned subsidiary of Symphogen A/S.

“This is the optimal time to strengthen Symphogen’s global presence as our novel pipeline is advancing into the later-stages of clinical development,” said Kirsten Drejer, Ph.D., CEO of Symphogen.

Ms. Sax added, “Antibody therapeutics and technologies continue to drive significant value for the pharmaceutical industry. New Jersey has long been recognized as good centralized location for bioscience companies with global development programs and multiple worldwide partnerships, so it was an easy decision for Symphogen to base our US business here. With Symphogen’s growing pipeline and leading antibody discovery and expression technologies, we are excited about the company’s future prospects and hope to capitalize on these opportunities by having broad access to physicians, patients and partners.”

About Symphogen

Symphogen is developing superior antibody therapeutics to help people with serious diseases. With its proprietary SymplexTM discovery and SympressTM manufacturing platforms, the company captures the diversity and specificity of the natural immune response in rationally designed recombinant antibody compositions. Symphogen is maturing a diversified pipeline of internal and partnered products across multiple indications including cancer and infectious disease. Symphogen is a private biopharmaceutical company with more than 70 employees, and its headquarters are based in Copenhagen, Denmark. www.symphogen.com

Symphogen, Inc.
Kirsten Drejer, CEO, +45 45 26 50 59
+45 22 10 99 59 (cell)
kd@symphogen.com
or
Media:
Karen Miller, Manager, +1-609-951 2295
US Business Operations
kmi@symphogen.com


Copyright © 2008 Business Wire. All rights reserved.
Share/Save/Bookmark

Article : Symphogen Opens US Operations in Princeton, New Jersey
Print this article
Share this article

Stay Updated

News gadget on your Google homepage
Subscribe to a news feed in Google Reader



Related News

Magna Entertainment Corp. files fifteenth default status report
AURORA, ON, Nov. 25 /PRNewswire/ - Magna Entertainment Corp. ("MEC" or the "Company") filed this news release as its fifteenth bi-weekly default status report under National Policy 12-203 of the Canadian Securities Administrators, pursuant...

Air China Awarded at CITM in Kunming
BEIJING, Nov. 25 /PRNewswire-Asia/ -- Air China has won awards for "Best Organization" and "Best Booth" at the China International Travel Market (CITM), held in Kunming, China, between the 19th...

Air China Transports 10,000 Pilgrims to Mecca
BEIJING, Nov. 25 /PRNewswire-Asia/ -- Between 30th October to 18th November, Air China transported nearly 10,000 pilgrims to the holy meeting site of Mecca, Saudi Arabia. There are nearly 20 million Muslims in China

Being Frugal on Black Friday: Making Wise Spending Decisions for the Holidays
A new online campaign--"Festive & Frugal"--is encouraging people to think twice about purchases and celebrate the holidays without overspending. The campaign, sponsored by Orange County's The Frugality Game, is using social media tools like Facebook to spread the word that gifts...

Cap-and-Trade Bill Targets Coal Industry, Exports Jobs, Massey Energy's Don Blankenship Says in Interview With The Hill, a Prominent Washington Newspaper
JULIAN, W.Va., Nov. 25 /PRNewswire/ -- In an extensive interview with The Hill newspaper last week on

Research and Markets: Regional Supply-Demand and Circulation of Corn in China - Corn is the Second Largest Grain Crop in China
DUBLIN - Research and Markets (http://www.researchandmarkets.com/research/6620b0/regional_supplyde) has announced the addition of the

Research and Markets: The Global Market for Flavours & Fragrances 2009 Volume 3 - Asia-Pacific
DUBLIN - Research and Markets (

Have your Say
Name
Email
Subject
Your Comment

Enter Verification code
 
  

 
Follow The Earth Times
Subscribe to RSS Follow Earth Times on TwitterNews by email
Share/Save/Bookmark
 
 



 
Subscribe to free Earthtimes
News Alerts by Email Click here
For RSS Feeds Click here
or Create your own RSS

Add to Google Toolbar
Breaking News
Press Releases

 


The Earth Times
News Category

© 2009 www.earthtimes.org, The Earth Times, All Rights Reserved | Privacy Policy
Earth Times accept no responsibility or liability either directly or indirectly for views or opinions expressed in articles or comments.